Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Kellogg Company K from Neutral to Outperform. The price target for Kellogg has been raised from $72 to $76. Kellogg shares closed at $66.25 on Friday. Analysts at Goldman Sachs upgraded Teva Pharmaceutical Industries Ltd (ADR) TEVA from Neutral to Buy. Teva Pharmaceutical shares closed at $61.72 on Friday. Jefferies upgraded KeyCorp KEY from Hold to Buy. The price target for KeyCorp has been raised to $15.50. KeyCorp shares closed at $13.07 on Friday. Analysts at Maxim Group upgraded HP Inc HPQ from Hold to Buy. The price target for HP has been lowered from $28 to $17. HP shares closed at $14.06 on Friday. Analysts at Nomura upgraded PepsiCo, Inc. PEP from Reduce to Neutral. PepsiCo shares closed at $100.10 on Friday. Sterne Agee CRT upgraded Synchrony Financial SYF from Neutral to Buy. Synchrony Financial shares closed at $31.36 on Friday. Analysts at UBS upgraded Genomic Health, Inc. GHDX from Neutral to Buy. Genomic Health shares closed at $28.69 on Friday. BMO Capital upgraded James River Group Holdings Ltd JRVR from Market Perform to Outperform. James River Group shares closed at $31.09 on Friday. Deutsche Bank upgraded Willis Group Holdings PLC WSH from Sell to Hold. The price target for Willis Group has been raised from $41 to $47. Willis Group shares closed at $45.70 on Friday. Canaccord Genuity upgraded Dicks Sporting Goods Inc DKS from Hold to Buy. The price target for Dick's Sporting has been raised from $46 to $48. Dick's Sporting shares closed at $38.99 on Friday.